Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 5 of 23
Esophagogastric Junction Distensibility During Hiatal Hernia Repair
NCT04450628
Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
NCT04113018
Pilot Study of SGRT Alone vs. SGRT With Fiducials for Breath Hold SBRT tx of the Lung
NCT04060927
Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain(TENS Study)
NCT04058652
IORT-Breast at Medical Center Navicent Health
NCT04595435
Shaving Satisfaction in Males With Skin Irritation From Shaving
NCT03569956
Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
NCT03505762
Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients
NCT02835222
A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer
NCT03246347
Understanding and Predicting Breast Cancer Events After Treatment
NCT02791581
Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC
NCT03141359
Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer
NCT02942355
Observational Study of Dental Outcomes in Head and Neck Cancer Patients
NCT02057510
Clinical Registry of Long-Term Dental Outcomes in Head and Neck Cancer Patients
NCT05325970
Medical Mistrust Among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex With Men (HLMSM)
NCT06132672
Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct
NCT05054790
Amnion Membrane Powder Mohs Study
NCT07680023
A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)
NCT07614022
MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation
NCT07632157
Placental Cells for Diabetic Foot Ulcers
NCT07686094
Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora
NCT03463239
Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations
NCT06013449
Narrative Medicine Effects on Burnout and Stress
NCT07136597
Methadone Pharmacokinetics in Cardiac Surgery
NCT07226245
Intraosseous Antibiotics for Osseointegration
NCT07621094
IPP Placement & Intracavernosal Block
NCT07246642
The EDICT Trial - Therapy for Inflammatory Bowel Disease Flares
NCT07143188
Vibegron for ENergy Thinking and Resilience in Aging
NCT06987383
Multisensory Rehabilitation of Vision Loss After Cortical Damage
NCT07659691
Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass
NCT06861881
The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma
NCT07560826
Trial of CGM Technology in Persons Living With Prediabetes
NCT07639593
Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients
NCT06744712
Ameliorating Stroke-induced Hemianopia Via Multisensory Training
NCT05894434
Liposomal Bupivacaine vs Perineural Adjuvants in Adductor Canalf and iPACK Blocks in Total Knee Arthroplasty
NCT07097493
Azithromycin for Cerclage Prophylaxis
NCT07608562
Tailoring TM-HTN Intervention for Black Patients
NCT06593119
Opzelura Experience Study
NCT07661979
Evaluation of Hyivy Floora in Managing Interstitial Cystitis/Bladder Pain Syndrome/High-tone Pelvic Floor Dysfunction
NCT07038512
Examining Analgesic Synergy and Efficacy in Trauma Care
NCT07435077
Peripheral Venous Pressure (PVP) Trial
NCT07400042
Optimizing Sustainable Cuff Access and Training Pathways for Self-Measured Blood Pressure Monitoring in Primary Care
NCT07693699
A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial
NCT07282444
Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock
NCT06746753
Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia
NCT03474718
Breast-milk Enema Administration to Stimulate Passage of Meconium
NCT07661992
Thermal Preconditioning in Mastectomy Patients With Immediate Breast Reduction
NCT07516483
Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers
NCT07661355
Mindfulness in Nonflaccid Facial Paralysis
NCT07127016
Auditory Stimulation for Insomnia and Depression
NCT07553364
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.